Awarded to
Avansor Pharma Oy; Orion Oyj; Accord Healthcare Oy; Celltrion Healthcare Finland Oy
- Awarded value
- €28,250
- Award date
- Bids received
- 8 over 2 lots
- Record with this buyer
- 1 first contract from this buyer in the register
- Back on the market
- Dec 2027 How we know
When this contract comes back
This contract runs about 16 months, so it is back on the market around December 2027.
Every contract expiring, on the radarSummary
Machine-generated summaryThe wellbeing services areas of Pirkanmaa, Etelä-Pohjanmaa and Kanta-Häme jointly purchased medicines through the hospital pharmacy of the Pirkanmaa wellbeing services area. The contract covers rivaroxaban capsules and tablets in 10 mg, 15 mg and 20 mg strengths (ATC: B01AF01) and denosumab injection solutions (ATC: M05BX04) with Finnish marketing authorisation. Bidders could submit offers for one or more products, by manufacturer, in either or both parts. The contract was awarded to Avansor Pharma Oy, Orion Oyj, Accord Healthcare Oy and Celltrion Healthcare Finland Oy for EUR 28,250. The award date was 5 August 2026. The supply period runs from 1 September 2026 to 31 December 2027.
Description
2 lots
- Lot 1
- Rivaroksabaanikapselit ja -tabletit 10 mg, 15 mg ja 20 mg
- Lot 2
- Denosumabi-injektionesteet
- How tenders are scored
- Price
As the official notice states them.
Official source
Source: TED - Tenders Electronic Daily (Publications Office of the EU)
Always verify details on the official notice.
Report an error in this notice
Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 2 days ago
What this buyer has paid before
Based on 5 comparable contracts this buyer awarded in this sector over the last 4 years.
- This award
- €28,250
- Median award
- €650,000
- Middle half of past awards
- €220,000 to €1.0M
The award is smaller than three in four past awards.
Most recent awards
- Suomi - Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet - I.v.-immunoglobuliinivalmisteiden hankinta kaudella 2026 - 2027 €7,000,000
- Suomi - Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet - Gadoteerihappoa sisältävien lääkevalmisteiden hankinta kaudelle 1.5.2026-31.12.2027 €220,000
- Suomi - Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet - Glofitamabivalmisteen (Columvi) suorahankinta €1,000,000
- Suomi - Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet - Nusinerseenivalmisteen (Spinraza) suorahankinta €650,000
Award values as published by the official sources. Use them as a guide, not a rule: scope, lots and duration differ between contracts.
The buyer
Full buyer profilePirkanmaan hyvinvointialue; Etelä-Pohjanmaan hyvinvointialue; Kanta-Hämeen hyvinvointialue
- notices in the register
- 10
- awards
- 7
- awarded in total
- €8.9M
One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.
Recent awards
- Suomi - Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet - Gadoteerihappoa sisältävien lääkevalmisteiden hankinta kaudelle 1.5.2026-31.12.2027
- Suomi - Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet - Glofitamabivalmisteen (Columvi) suorahankinta
- Suomi - Lääketieteelliset laitteet, farmaseuttiset valmisteet ja henkilökohtaiseen hygieniaan liittyvät tuotteet - Nusinerseenivalmisteen (Spinraza) suorahankinta
Market context
- open now in Medical equipment & pharmaceuticals
- 8,119
- median open notice
- €311,053
Who wins in this market
Many suppliersFinland · Medical equipment & pharmaceuticals
- different companies won awards here
- 414
- of the awards went to the three most frequent winners
- 8%
- buyers awarded contracts here
- 164
Based on 616 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 3.0
- of those lots received a single tender
- 17%
- of the awards went to companies based in another country
- 9%
- of the tenders came from another country
- 2%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
3
days left
€115,000
est. value
6
days left
€100,000
est. value
Awarded before
Never miss a tender like this
32 new notices in Medical equipment & pharmaceuticals in Finland in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, Medical equipments, pharmaceuticals and personal care products: an email when new tenders arrive under it, no account needed.